Bio and generic demand driving increased internationalisation and renewed optimism amongst industry The Japanese pharma market is expected to grow quickly in 2019 following the release of a new report published ahead ofCPhI Japan 2019. The trade exhibition (18-20 March, 2019) will open its
More
Kemira and General Electric (GE) are excited to announce that, effective immediately, Kemira’s Paper Segment will furnish GE Water &
More
Difficult-to-study diseases such as Alzheimer’s, schizophrenia, and autism now can be probed more safely and effectively thanks to an innovative
More
[column]The U.S. Food and Drug Administration has approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after
More
[column]The U.S. Food and Drug Administration has approved a new use of Gleevec (imatinib) to treat children newly diagnosed with
More
The U.S. Food and Drug Administration is alerting health care providers and patients of a voluntary nationwide recall of all
More
[column]Two mutations central to the development of infantile myofibromatosis (IM) – a disorder characterized by multiple tumors involving
More
[column]Advances in genetic profiling have allowed doctors to match more of their cancer patients with treatments that will target their
More
4 symposiums on Oncology, General Biologics, Immunology and Cardiology at 6th annual BioPharma Asia Convention 2013. Research on Oncology, Cardiology, Immunology and
More
[column]A study of older patients with advanced head and neck cancers has found that where they were treated significantly influenced
More
Rotterdam, The Netherlands– IMCD Group B.V. announces it has acquired the business of Indchem International, an established player in the
More